Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion

Amkraut, 1987, Delivery of therapeutic agents by osmotic pumps, 131 Bailon, 1988, Purification and partial characterization of an interleukin 2-Pseudomonas exotoxin fusion protein, Biotechnology, 6, 1326, 10.1038/nbt1188-1326 Bottazzo, 1985, In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, New Engl. J. Med., 313, 353, 10.1056/NEJM198508083130604 Case, 1989, Chimeric cytotoxin IL-2-PE40 delays and mitigates adjuvant-induced arthritis in rats, 86, 287 Chaudhary, 1987, Activity of a recombinant fusion protein between transforming growth factor types α and Pseudomonas toxin, 84, 4538 Fara, 1988, Osmotic pumps, 137 Heidecke, 1984, Interaction between T lymphocyte subsets supported by interleukin-2 rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats, J. Immun., 133, 582 Hwang, 1987, Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in, E. coli. Cell, 48, 129 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (Lond.), 227, 680, 10.1038/227680a0 Lemm, 1986, Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis, Clin. exp. Immun., 64, 71 Lorberboum-Galski, 1989, Cardiac allograft survival in mice treated with IL-2-PE40, 86, 1008 Lorberboum-Galski, 1988, Cytotoxic activity of an Interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli, 85, 1922 Lorberboum-Galski, 1988, Interleukin 2 (IL-2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL-2 receptor, J. biol. Chem., 263, 18650, 10.1016/S0021-9258(18)37334-4 Naito, 1988, Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide, Cancer Res., 48, 101 Ogata, 1988, IL-2-PE40 is cytotoxic for activated T lymphocyte expressing IL-2 receptors, J. Immun., 141, 4224 Ray, 1988, Implatable osmotically powered drug delivery systems, 120 Roberge, 1989, Selective immunosuppression of activated T-cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveretinitis (EAU), J. Immun. Rosenstein, 1986, Extraction of intravascular fluid mediated by the systemic administration of recombinant interleukin 2, J. Immun., 137, 1735 Rozenszajn, 1986, Induction of experimental autoimmune uveoretinitis by T cell lines, Immunology, 57, 559 Selby, 1984, Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohistological and cell isolation techniques, Gut, 25, 32, 10.1136/gut.25.1.32 Shapiro, 1987, Monoclonal anti-IL-2 receptor antibody in primate renal transplantation, 19, 594 Ting, 1984, Induction of suppressor T cells by interleukin 2, J. Immun., 133, 261 Waldmann, 1989, Multichain interleukin-2 receptor. A target for immunotherapy in lymphoma, J. natn. Cancer Inst., 81, 914, 10.1093/jnci/81.12.914 Wall, 1983, Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies, J. clin. Endocrin. Metab., 56, 164, 10.1210/jcem-56-1-164 Yocum, 1986, Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats, Arthritis Rheum., 29, 262, 10.1002/art.1780290215